The UMP Healthcare Board and the Human Health Board jointly announce that on 15 February 2023, the Strategic Cooperation Agreement was entered into between UMP Healthcare and Human Health, in relation to a strategic alliance for a term of three years to develop a holistic ecosystem that provides comprehensive healthcare services in Hong Kong and Macau. The UMP Healthcare Board and the Human Health Board jointly announce that on
15 February 2023, as furtherance of the strategic alliance between UMP Healthcare Group and the Human Health Group, UMP Medical Centre (an indirect wholly-owned subsidiary of UMP Healthcare) and Actwise (an indirect wholly-owned subsidiary of Human Health) entered into the Investment Agreement, to form a joint venture in Procare TST pursuant to which: Actwise shall invest in 20% of the issued shares of Procare TST at a total
investment sum of approximately HKD 11.6 million; UMP Medical Centre shall hold 55% of the issued shares of Procare TST and invest in Procare TST at a total investment sum of approximately HKD 31.9
million; and UMP Medical Centre shall procure another shareholder of Procare TST (which holds 25% of the issued shares of Procare TST) to invest in Procare TST at a total investment sum of approximately HKD 14.5 million. Leveraging over 30 years of strong healthcare development and industry experience, UMP Healthcare Group has been engaging in the provision of corporate healthcare solution services with a strong customer base consisting of multi-national corporations and insurance companies and has established extensive medical clinic service points in Hong Kong and Macau. The current UMP Healthcare's network consists of approximately 1,000 self-owned and affiliated medical service points across Hong Kong and Macau, providing services including family medicine, specialist consultation, dental care, diagnostic imaging and laboratory, preventive medicine and health assessment, day surgery and endoscopy.